AI medical device companies face major reimbursement hurdles when trying to secure coverage, CPT codes, and payment from ...
The liability, safety, and accuracy questions underlying one creative proposal, in this week's AI Prognosis newsletter.
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors.  | Dexcom said Smart Basal is the ...
Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance.
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the ...